CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
Business Wire India CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease,…
